GeneBioTechCo.,Ltd. · 주요사항보고서(자기주식취득결정)
Material Event Report (Treasury Stock Acquisition Decision)
6.3
(주)진바이오텍
Material Event Report / KRX Mandatory Disclosure
| To: Financial Services Commission / Korea Exchange | 2026-11-16 |
| Company Name: | (주)진바이오텍 |
| CEO: | 이 찬 호 |
| Head Office Address: | 충남 공주시 계룡면 신원사로 166 |
| (Tel) 041-853-9961 |
| (홈페이지)http://www.genebiotech.co.kr |
| Preparer: | (Title) Director | (성 명) 김기태 |
| (Tel) 02-6300-8222 |
Decision on treasury stock acquisition
| 1. Shares to Be Acquired (shares) | Common Shares | 86,000 |
| Other Shares | - |
| 2. Planned Acquisition Amount (KRW) | Common Shares | 434,300,000 |
| Other Shares | - |
| 3. Expected Acquisition Period | Start Date | 2026-11-17 |
| End Date | 2027-02-16 |
| 4. Expected Holding Period | Start Date | - |
| End Date | - |
| 5. Purpose of Acquisition | 임직원 성과보상 및 주가안정 |
| 6. Acquisition Method | 코스닥시장을 통한 장내 직접취득 |
| 7. Entrusted Investment Broker | NH투자증권(NH Investment & Securities Co., Ltd) |
| 8. Treasury Shares Held Before Acquisition | Acquisition within distributable profits (shares) | Common Shares | - | Ratio (%) | - |
| Other Shares | - | Ratio (%) | - |
| Other Acquisitions (shares) | Common Shares | - | Ratio (%) | - |
| Other Shares | - | Ratio (%) | - |
| 9. Acquisition Resolution Date | 2026-11-16 |
| - Independent (Outside) Directors* Present | Present (persons) | 1 |
| Absent (persons) | - |
| - Auditor (audit committee member not an independent (outside) director*) attendance | Present |
| 10. Daily Purchase Order Limit (1 days) | Common Shares | 8,600 |
| Other Shares | - |
* Independent directors for listed companies; outside directors for unlisted companies
| 11. Other Matters Relevant to Investment Decisions |
- 상기 '1.취득예정주식(주)'은 이사회 결의일 직전 거래일 한국거래소 종가를 기준으로 하여 산정하였습니다.(2026-11-13, 5,050원)- 당사는 상기 '2. 취득예정금액(원)'에 기재한 금액을 기준으로 자기주식을 취득할 예정이며, 향후 주가 변동에 따라 실제 취득주식수량 및 취득금액은 변동될 수 있습니다.- 상기 '4. 보유예상기간'은 회사의 재무상태, 시장환경 변화. 경영환경 등을 고려하여 결정할 예정입니다.- 상기 '5. 취득목적'과 관련하여 당사는 2026-11-16 이사회 결의에 따라 임직원 성과보상 및 주가안정에 사용할 목적으로 자기주식을 취득하는 것입니다. 취득한 자기주식의 처분에 관한 사항은 향후 임직원 성과보상 등 경영 환경에 따라 결정할 예정입니다.- 상기 10. 1일 매수 주문수량 한도는 아래의 산출 근거에 따라 계산되었습니다.※ [(1)과 (2) 중 많은 수량]과 (3) 중 적은 수량 (1) 취득신고주식수의 10% : 8,600주 (2) 이사회결의일 전일로부터 1개월간 일평균거래량의 25% : 3,788주 (3) 발행주식 총수의 1% : 86,105주
| 【Treasury Share Acquisition Limit】 |
| Item | Amount |
| 1. Distributable Profit Limit under the Commercial Act as of Prior Fiscal Year-End | a. Net Assets | 39,612,500,162 |
| b. Share Capital | 4,305,293,500 |
| C. Sum of Capital Reserve and Legal Reserve Accumulated through Prior Fiscal Year | 13,924,385,689 |
| D. Unrealized Gains Prescribed by Presidential Decree | 310,598,711 |
| Subtotal (A-B-C-D) | 21,072,222,262 |
| 2. Treasury Share Acquisition Amount Since Prior Fiscal Year-End | - |
| 3. Dividends Resolved at the AGM Since Prior Fiscal Year-End and Related Legal Reserve | 473,582,285 |
| 4. Quarterly/Interim Dividends Resolved by the Board Since Prior Fiscal Year-End and Related Legal Reserve | 284,149,371 |
| 5. Trust Contract Amount | - |
| 6. Acquisition Cost of Treasury Shares Disposed Since Prior Fiscal Year-End (Moving Average Method) | - |
| Treasury share acquisition limit (1-2-3-4-5+6) | 20,314,490,606 |
| 【Treasury Shares Held Before Acquisition Resolution】 |
| Acquisition method | Type of Shares | Beginning quantity | Change in quantity | Ending quantity | Remarks |
| Acquired (+) | Disposed (-) | Retired (-) |
| Acquisition within distributable profits | Direct acquisition | Direct On-Market Acquisition | Common Shares | - | - | - | - | - | - |
| Other Shares | - | - | - | - | - | - |
| Direct OTC acquisition | Common Shares | - | - | - | - | - | - |
| Other Shares | - | - | - | - | - | - |
| Tender offer | Common Shares | - | - | - | - | - | - |
| Other Shares | - | - | - | - | - | - |
| Subtotal (a) | Common Shares | - | - | - | - | - | - |
| Other Shares | - | - | - | - | - | - |
| Acquisition under trust agreement | Shares held by trustee | Common Shares | - | - | - | - | - | - |
| Other Shares | - | - | - | - | - | - |
| Shares held in kind | Common Shares | - | - | - | - | - | - |
| Other Shares | - | - | - | - | - | - |
| Subtotal (b) | Common Shares | - | - | - | - | - | - |
| Other Shares | - | - | - | - | - | - |
| Other acquisitions (c) | Common Shares | - | - | - | - | - | - |
| Other Shares | - | - | - | - | - | - |
| Total (a+b+c) | Common Shares | - | - | - | - | - | - |
| Other Shares | - | - | - | - | - | - |